VA Diagnostic Code 7719Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia):
Rated from 30% to 100% under § 4.117. Here is what the VA requires at each level.
Not the right code?
What each rating requires
The VA assigns the highest level your evidence actually supports. Read up the stack until your records stop matching.
- 100%
Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment
- 60%
Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission
- 30%
In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors
Notes on this code
These notes are part of the regulation. They change how the levels above are applied.
- Note (1): If the condition undergoes leukemic transformation, evaluate as leukemia under diagnostic code 7703
- Note (2): A 100 percent evaluation shall be assigned as of the date of hospital admission for peripheral blood or bone marrow stem cell transplant; or during the period of treatment with chemotherapy (including myelosuppressants). Six months following hospital discharge or, in the case of chemotherapy treatment, six months after completion of treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105 of this chapter
Chronic Myelogenous Leukemia (CML) — VA Disability Rating (Diagnostic Code 7719)
Also known as chronic myeloid leukemia or chronic granulocytic leukemia
Body system: Hemic and Lymphatic Systems Regulation: 38 CFR § 4.117, Diagnostic Code 7719
Understanding This Condition
Chronic myelogenous leukemia (CML) is a cancer that affects the blood and bone marrow. Under VA's rating schedule, it falls within the Hemic and Lymphatic Systems and is rated according to how it is being treated and whether it is in apparent remission.
The VA rates CML at different levels depending on the type and intensity of treatment required. Below is a plain-language look at the available rating levels and what the VA considers when assigning them.
Available Rating Levels
The rating schedule for CML includes three levels:
100% Rating
Assigned when the condition requires:
- A peripheral blood or bone marrow stem cell transplant, or
- Continuous myelosuppressive or immunosuppressive therapy treatment
60% Rating
Assigned when the condition requires:
- Intermittent myelosuppressive therapy, or
- Molecularly targeted therapy with tyrosine kinase inhibitors, or
- Interferon treatment — when not in apparent remission
30% Rating
Assigned when the condition is:
- In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors
What the VA Looks For
When rating CML, the VA focuses on the treatment being received and whether the condition is in apparent remission. Key factors include:
- Whether a stem cell transplant (peripheral blood or bone marrow) is required
- Whether treatment is continuous or intermittent
- The type of therapy involved — such as myelosuppressive therapy, immunosuppressive therapy, molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment
- Whether the condition is in apparent remission
Important Notes
Leukemic transformation. If the condition undergoes leukemic transformation, it is evaluated as leukemia under Diagnostic Code 7703.
The 100% rating and mandatory re-examination. A 100 percent evaluation is assigned as of the date of hospital admission for a peripheral blood or bone marrow stem cell transplant, or during the period of treatment with chemotherapy (including myelosuppressants).
- Six months following hospital discharge, or
- Six months after completion of chemotherapy treatment,
the appropriate disability rating is determined by a mandatory VA examination. Any reduction in evaluation based on that or any subsequent examination is subject to the provisions of § 3.105.
These criteria are a rendering of § 4.117, diagnostic code 7719. The official version is the one that governs your rating.
View official sourceHow to claim this
Knowing the criteria is the first half. Getting your file to show them is the second.
Find your level in the stack
Read each rung against what your medical records already say. The level your records document today is the one the VA can support today.
Name the gap
Look at the rung above yours and write down exactly what it asks for that your file does not show yet — a diagnosis, a measurement, a prescribed brace, a doctor’s opinion linking it to service.
Claim it by code
File under diagnostic code 7719 and attach the evidence for the level you are asking for. Other Hemic and Lymphatic Systems codes may cover your secondary conditions.
Find out which rating your evidence supports.
Six reads your records against these exact criteria and tells you what the VA is still missing.
Start for freeAll 21 Hemic and Lymphatic Systems codes →